12º COBRAPEM

Convidados Internacionais

  • Adda Grimberg, Children's Hospital of Philadelphia

    Adda Grimberg is Associate Professor of Pediatrics at the Perelman School of Medicine, University of Pennsylvania, and Scientific Director of the Diagnostic and Research Growth Center at the Children's Hospital of Philadelphia. She received her undergraduate and medical education at Cornell University, and completed both her residency in Pediatrics and fellowship in Pediatric Endocrinology at the Children's Hospital of Philadelphia. She was subsequently appointed to the faculty in the same institution in the Division of Pediatric Endocrinology and Diabetes. Trained as a translational physician scientist, Dr. Grimberg's research focuses on the growth hormone (GH)/insulin-like growth factor (IGF) axis and clinical issues related to child growth. One of her principal research areas involves describing, understanding and addressing disparities in the evaluation and management of growth faltering. She is interested in GH as an illustrative pipeline issue - how the advent of an expensive therapeutic transformed a fundamental aspect of pediatric health care from its medical focus into socially driven health care consumerism. Dr. Grimberg has published over 70 scientific articles, reviews and textbook chapters. Her research has been recognized with numerous awards, including the Pediatric Endocrine Society Genentech Clinical Scholar Award, and with coverage in multiple media venues in the United Sates and abroad, including the New York Times. Dr. Grimberg was appointed Chair of the taskforce charged with drafting the new guidelines for GH and IGF-I use in children and adolescents for the Pediatric Endocrine Society, serves on the Federal Advisory Committee for the National Children's Study of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, and is an invited participant in an up-coming consensus workshop on the safety of GH treatment on behalf of the European Society of Pediatric Endocrinology, the Growth Hormone Research Society and the Pediatric Endocrine Society.
  • Alejandro Martínez Aguayo

    Alejandro Martinez-Aguayo is an Associate Professor of Paediatric Endocrinology at the Pontificia Universidad Católica de Chile. He studied medicine and did his pediatrics fellow at the Universidad de Concepción. Between 2001-04 he did his pediatrics endocrinology training at the Instituto de Investigaciones Materno Infantil, Universidad de Chile. During 2010 he was an academic visitor at UCL Institute of Child Health, UK. Martinez-Aguayo's research interests include adrenal disorders related with hypertension and congenital adrenal hyperplasia. He is an active member of Chilean Endocrinology and Diabetes Society, SLEP and ESPE. He has published approximately 30 peer reviewed papers and reviews, as well as book chapters and guidance documents.
  • Jeffrey Baron, National Institutes of Health

    Jeffrey Baron is a senior investigator and head of the Section on Growth and Development in NICHD. He received his M.D. degree from the University of Texas Southwestern Medical School. He completed a residency in pediatrics at Yale-New Haven Hospital and a fellowship in pediatric endocrinology in the Developmental Endocrinology Branch of NICHD. The Section on Growth and Development, headed by Dr. Baron, investigates the cellular and molecular mechanisms governing childhood growth and development. Recently this research group has focused on the mechanisms that allow rapid proliferation and hence rapid body growth in young mammals and subsequently suppress proliferation, thus setting a fundamental limit on the adult body size of the species. One goal of this work is to gain insight into the many human genetic disorders that cause childhood growth failure and overgrowth. In addition, further investigation of the identified growth-limiting mechanisms may lead to broader medical applications, because disruption of these mechanisms may contribute to oncogenesis, and conversely transient therapeutic suspension of growth-limiting mechanisms in adult cells might be used to achieve tissue regeneration. In addition to his research role, Dr. Baron serves as an attending physician for the pediatric endocrinology clinic and consultative service and teaches clinical fellows in the NICHD pediatric endocrinology training program.
  • Stephen Rosenthal, University of California at San Francisco

    Dr. Stephen M. Rosenthal is program director for Pediatric Endocrinology, director of the Endocrine Clinics, co-director of the Disorders of Sex Development (DSD) Clinic and co-founder of the Pediatric Diabetes Program at UCSF Benioff Children's Hospital. He is also a professor of clinical pediatrics at UCSF.

    In addition, Rosenthal conducts research on DSD, transgender health in youth and adolescents, and on pediatric and adolescent Type 1 diabetes. He led an effort to create the Child and Adolescent Gender Center (CAGC), a program that brings together experts from many disciplines to provide comprehensive medical and mental health care, as well as education and advocacy, for gender non-conforming/transgender youth and adolescents. He is co-chair of the CAGC steering committee and medical director of the CAGC.

    Rosenthal earned a bachelor's degree at Yale University and a medical degree at Columbia University, where he also completed a residency in pediatrics. He completed a fellowship in pediatric endocrinology at UCSF.
  • Stuart Alan Weinzimer

    I earned my bachelor's degree in molecular biochemistry and biochemistry at Yale University and medical degree at the Albert Einstein College of Medicine. I completed my residency training in pediatrics and fellowship training in pediatric endocrinology at the Children's Hospital of Philadelphia (CHOP), and joined the faculty in the Department of Pediatrics at the University of Pennsylvania. In 2002 I returned to Yale to focus my research on the continuous glucose sensors and insulin pumps toward the development of an artificial pancreas. I am the Principal Investigator of several NIH- and JDRF- funded artificial pancreas projects. In 2006 I earned Yale's Mae Gailani Award for Outstanding Clinical Care & Research, and in 2009 I received the Dream Award from the Greater New Haven Chapter of the JDRF. In 2011 I was awarded, along with other principal investigators in the JDRF Continuous Glucose Monitoring Study Group, the Mary Tyler Moore and S. Robert Levine, MD Excellence in Clinical Research Award.